NeuroSense Therapeutics Ltd. (NRSN) Reports FY results
Tweet
Share
E-mailGet Alerts NRSN Hot Sheet
Join SI Premium – FREE
NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) reported FY EPS of ($0.54).
For earnings history and earnings-related data on NeuroSense Therapeutics Ltd. (NRSN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ericsson (ERIC) Tops Q2 EPS by 3c
- Berenberg Downgrades QIAGEN NV (QIA:GR) (QGEN) to Hold
- UBS Upgrades UL Solutions Inc (ULS) to Buy
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
